ALGETA ASA
Registration details
Company overview
ALGETA ASA was a Norwegian allmennaksjeselskap (public limited company), organisation number 979380593, with business address Kjelsåsveien 172 A, 0884 Oslo. The company no longer exists. The Register of Business Enterprises deleted it on 1 September 2014 after a merger into another Norwegian company (see Group structure); it did not end in bankruptcy. The orgnr is a main legal unit (enhet), not a sub-unit. The register’s name history records the name ANTICANCER THERAPEUTIC INVENTIONS AS from 11 November 1997. It became ALGETA AS on 26 April 2003 and ALGETA ASA on 26 July 2004.
Algeta described itself as a company developing, manufacturing and marketing targeted cancer therapies. Its lead product was Xofigo (radium Ra 223 dichloride), an alpha particle-emitting pharmaceutical for castration-resistant prostate cancer with symptomatic bone metastases. Xofigo was developed and commercialised under a September 2009 agreement with Bayer. It received US FDA approval in May 2013 and EU marketing authorisation in November 2013. Algeta also ran an early-stage Targeted Thorium Conjugates (TTC) platform.
Oslo Børs approved admission of Algeta’s shares to listing on 1 March 2007, and on 26 March 2007 the company announced that it had raised NOK 250 million in its share offering. It traded under the ticker ALGETA. For the full year 2013, Algeta reported operating revenue of NOK 635 million, against NOK 627 million in 2012, in its results announcement of 5 February 2014. That announcement does not label the figures as company-level or consolidated, and the company was registered as a group parent for 2013. Oslo Børs resolved on 19 March 2014 to delist the shares, with 21 March 2014 as the last day of listing. The Regnskapsregisteret API returns no accounts for this number.
Sources
- Brønnøysundregistrene, Enhetsregisteret API: organisation number 979380593 (deleted unit record with name history). Record shows deletion date 1 September 2014; retrieved 20 October 2026. https://data.brreg.no/enhetsregisteret/api/enheter/979380593
- Brønnøysundregistrene, Foretaksregisteret announcement: Nytt foretaksnavn ALGETA ASA. Published 26 July 2004; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20040000274387&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Kunngjøringer: list of 167 announcements for 979 380 593. Announcements dated 13 January 2000 to 1 September 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_nr.jsp?orgnr=979380593
- Brønnøysundregistrene, Foretaksregisteret announcement: Sletting etter fusjon (deletion after merger). Published 1 September 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000408125&sokeverdi=979380593&spraak=nb
- Algeta ASA via Oslo Børs NewsWeb, “Algeta results for the fourth quarter and full year 2013”. Published 5 February 2014; retrieved 20 October 2026. https://newsweb.oslobors.no/message/345059
- Oslo Børs via NewsWeb, “ALGETA ASA NOTERES PÅ OSLO BØRS” (admission to listing). Published 1 March 2007; retrieved 20 October 2026. https://newsweb.oslobors.no/message/145755
- Algeta ASA via Oslo Børs NewsWeb, “ALGETA RAISES NOK 250 MILLION IN SUCCESSFUL OFFERING”. Published 26 March 2007; retrieved 20 October 2026. https://newsweb.oslobors.no/message/147410
- Oslo Børs via NewsWeb, “Delisting”. Published 19 March 2014; retrieved 20 October 2026. https://newsweb.oslobors.no/message/348528
- Brønnøysundregistrene, Regnskapsregisteret announcement: Godkjent årsregnskap 2013. Published 12 July 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000292551&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Regnskapsregisteret API: accounts for 979380593 (returned HTTP 404). No publication date; retrieved 20 October 2026. https://data.brreg.no/regnskapsregisteret/regnskap/979380593
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Officers
Directors and officers of ALGETA ASA
The Register of Business Enterprises published the board and general manager of ALGETA ASA up to its deletion on 1 September 2014. The last board change, published on 26 March 2014 after the takeover, lists five people. Oliver Rene Rittgen was chair of the board (styrets leder). Johanna Kristiina Kouru, Susanne Öngör, Torstein Myhre and Johannes Julius Michaelis were board members (styremedlem). The general manager (daglig leder) registered on the same date was Thomas Ramdahl. All these roles ended when the company was deleted after its merger, and none is current.
The board registered on 15 June 2013, before the takeover, had eight members. It was chaired by Stein Holst Annexstad, with John Edward Berriman as deputy chair (nestleder). The auditor registered on 21 July 2004 was PRICEWATERHOUSECOOPERS AS (org. no. 987009713).
Recent officer changes
- 14 March 2014: Algeta announced Thomas Ramdahl as Managing Director, succeeding Andrew Kay; the change was registered on 26 March 2014. Andrew Martin Kay had been registered as general manager on 14 February 2009.
- 26 March 2014: new five-member board registered, chaired by Oliver Rene Rittgen.
- 1 September 2014: company deleted after merger; all registered roles ended.
Data availability
Historical. The roles API returns no data for this deleted unit, so officers are taken from register announcements and Oslo Børs releases. These give names and roles but not nationality or country of residence.
Sources
- Brønnøysundregistrene, Foretaksregisteret announcement: Endring av styre (change of board). Published 26 March 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000082741&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Foretaksregisteret announcement: Endring av daglig leder (change of general manager). Published 26 March 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000082740&sokeverdi=979380593&spraak=nb
- Algeta ASA via Oslo Børs NewsWeb, “Thomas Ramdahl appointed Managing Director of Algeta ASA”. Published 14 March 2014; retrieved 20 October 2026. https://newsweb.oslobors.no/message/348197
- Brønnøysundregistrene, Foretaksregisteret announcement: Endring av styre (change of board). Published 15 June 2013; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20130000209255&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Foretaksregisteret announcement: Endring av daglig leder. Published 14 February 2009; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20090000041359&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Foretaksregisteret announcement: Endring av revisor (change of auditor). Published 21 July 2004; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20040000259112&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Foretaksregisteret announcement: Sletting etter fusjon (deletion after merger). Published 1 September 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000408125&sokeverdi=979380593&spraak=nb
Group Structure
Group structure of ALGETA ASA
Regnskapsregisteret’s approval notice for the 2013 accounts states that ALGETA ASA was registered as a parent company in a group (morselskap i konsern) for that year. From 6 March 2014 it was controlled by Aviator Acquisition AS (org. no. 998720516), which owned all of its shares after the compulsory acquisition. The compulsory-acquisition notice describes Aviator Acquisition AS as an indirectly wholly owned subsidiary of Bayer Aktiengesellschaft. A merger plan was filed on 28 May 2014, under which ALGETA ASA was absorbed by BAYER AS (org. no. 911268647). The creditor notice on the merger was published on 30 June 2014, and ALGETA ASA was deleted on 1 September 2014 with BAYER AS as the absorbing company.
Verified corporate relationships
| Entity | Country | Registration number | Relationship | Ownership | Status | Information date |
|---|---|---|---|---|---|---|
| AVIATOR ACQUISITION AS (now BAYER NORWAY AS) | Norway | 998720516 | Immediate parent (historical) | 98.2% from 6 March 2014; 100% after compulsory acquisition | Ended 1 September 2014 | 10 March 2014 |
| Bayer Aktiengesellschaft | Germany | HRB 48248 (LEI 549300J4U55H3WP1XT59) | Ultimate parent (historical) | Indirect; percentage not stated | Ended 1 September 2014 | 7 March 2014 |
| BAYER AS | Norway | 911268647 | Absorbing company in merger (successor) | Not applicable | Merger registered 1 September 2014 | 1 September 2014 |
Recent structural changes
- 6 March 2014: Bayer completed its voluntary takeover offer through Aviator Acquisition AS (98.2%).
- 7–10 March 2014: compulsory acquisition of the remaining shares; Aviator Acquisition AS became the sole shareholder.
- 1 September 2014: merger into BAYER AS registered and ALGETA ASA deleted.
Data availability
Historical. The relationships come from Brønnøysund announcements and Oslo Børs releases of 2014. The filings reviewed do not identify the subsidiaries Algeta held as a group parent, and no LEI was found for ALGETA ASA.
Sources
- Brønnøysundregistrene, Regnskapsregisteret announcement: Godkjent årsregnskap 2013. Published 12 July 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000292551&sokeverdi=979380593&spraak=nb
- Bayer via Oslo Børs NewsWeb, “Bayer completes voluntary takeover offer for Algeta”. Published 6 March 2014; retrieved 20 October 2026. https://newsweb.oslobors.no/message/347619
- Aviator Acquisition AS via Oslo Børs NewsWeb, “COMPULSORY ACQUISITION OF SHARES IN ALGETA ASA”. Published 7 March 2014; retrieved 20 October 2026. https://newsweb.oslobors.no/message/347774
- Brønnøysundregistrene announcement: Tvungen overføring av aksjer i datterselskap (compulsory transfer of shares). Published 10 March 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000061441&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Foretaksregisteret announcement: Fusjonsplan (merger plan received). Published 28 May 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000177635&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Foretaksregisteret announcement: Kreditorvarsel – Fusjon (creditor notice on merger). Published 30 June 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000257419&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Foretaksregisteret announcement: Sletting etter fusjon (deletion after merger). Published 1 September 2014; retrieved 20 October 2026. https://w2.brreg.no/kunngjoring/hent_en.jsp?kid=20140000408125&sokeverdi=979380593&spraak=nb
- Brønnøysundregistrene, Enhetsregisteret API: 998720516 BAYER NORWAY AS (former name AVIATOR ACQUISITION AS). Current record; retrieved 20 October 2026. https://data.brreg.no/enhetsregisteret/api/enheter/998720516
- Brønnøysundregistrene, Enhetsregisteret API: 911268647 BAYER AS. Current record; retrieved 20 October 2026. https://data.brreg.no/enhetsregisteret/api/enheter/911268647
- GLEIF API, LEI record 549300J4U55H3WP1XT59, Bayer Aktiengesellschaft (HRB 48248, Leverkusen). Golden copy of 19 October 2026; retrieved 20 October 2026. https://api.gleif.org/api/v1/lei-records/549300J4U55H3WP1XT59
- GLEIF API, LEI search by registeredAs “979380593” and “979 380 593” (0 results each; control 911268647 returned BAYER AS). Golden copy of 19 October 2026; retrieved 20 October 2026. https://api.gleif.org/api/v1/lei-records?filter%5Bentity.registeredAs%5D=979380593
Frequently asked questions
What does ALGETA ASA do?
ALGETA ASA (orgnr 979380593) was an Oslo-based oncology company that developed Xofigo (radium Ra 223 dichloride) for prostate cancer with bone metastases, together with Bayer. It also ran a Targeted Thorium Conjugates platform.
Who owns ALGETA ASA?
From 6 March 2014 Aviator Acquisition AS (org. no. 998720516) held 98.2% of ALGETA ASA. After the compulsory acquisition announced on 10 March 2014 it owned all shares, until the company merged into BAYER AS on 1 September 2014.
Who is ALGETA ASA's UBO (Ultimate Beneficial Owner)?
No natural-person beneficial owner of ALGETA ASA was identified. The filings name Bayer Aktiengesellschaft as the ultimate corporate parent from March 2014.
What is ALGETA ASA's company registration number?
ALGETA ASA was organisation number 979380593 in the Norwegian Register of Business Enterprises, a main legal unit.
Is ALGETA ASA still an active company?
No. The Register of Business Enterprises deleted it on 1 September 2014 after it merged into BAYER AS (911268647). It did not end in bankruptcy.
When was ALGETA ASA incorporated?
The register's name history starts on 11 November 1997, when it was named ANTICANCER THERAPEUTIC INVENTIONS AS. It became ALGETA AS on 26 April 2003 and ALGETA ASA on 26 July 2004.
What is ALGETA ASA's registered address?
Its business address was Kjelsåsveien 172 A, 0884 Oslo.
What legal structure is ALGETA ASA registered as?
It was a Norwegian allmennaksjeselskap (ASA), a public limited company.
What is ALGETA ASA's revenue?
Algeta reported operating revenue of NOK 635 million for 2013 and NOK 627 million for 2012 in its results announcement of 5 February 2014. The announcement does not say whether the figures are company-level or consolidated.
Is ALGETA ASA listed on a stock exchange?
ALGETA ASA was listed on Oslo Børs under the ticker ALGETA after admission was approved on 1 March 2007. Oslo Børs delisted it, with 21 March 2014 as the last day of listing.
Who are the officers/directors of ALGETA ASA?
The last registered board (26 March 2014) was chaired by Oliver Rene Rittgen, and Thomas Ramdahl was general manager. All roles ended when the company was deleted on 1 September 2014.
Does ALGETA ASA have a parent company or subsidiaries?
ALGETA ASA was a group parent in 2013 and became part of the Bayer group in March 2014. It was merged into BAYER AS (org. no. 911268647), which absorbed it on 1 September 2014.
When was Xofigo approved?
Xofigo, developed and commercialised with Bayer under a September 2009 agreement, received US FDA approval in May 2013 and EU marketing authorisation in November 2013.
How much did Bayer pay for Algeta?
Bayer's voluntary cash offer, made through Aviator Acquisition AS, was NOK 362 per share. Bayer announced completion on 6 March 2014.
How much did Algeta raise when it listed?
Oslo Børs approved admission of its shares on 1 March 2007, and on 26 March 2007 Algeta announced it had raised NOK 250 million in its share offering.
Who audited ALGETA ASA?
PricewaterhouseCoopers AS (987009713) was registered as auditor from 21 July 2004.